Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6854139 | 0.85 | KMT2A (0.35) | KMT2ASMN1; SMN2ALDH1A1HSD11B1EPHX2 | |
| SCHEMBL6860355 | 0.84 | KMT2A (0.34) | KMT2ASMN1; SMN2ALDH1A1HSD11B1EPHX2 | |
| SCHEMBL31084411 | 0.80 | HSD11B1 (0.36) | KMT2ASMN1; SMN2ALDH1A1HSD11B1EPHX2 | |
| SCHEMBL5248488 | 0.76 | THRB (0.36) | ALDH1A1HSD11B1EPHX2THRBCYP2C9 | |
| Hydrochloric Acid SCHEMBL27525501 | 0.75 | THRB (0.35) | ALDH1A1HSD11B1EPHX2THRBCYP2C9 | |
| Bromide SCHEMBL27511892 | 0.75 | THRB (0.35) | ALDH1A1HSD11B1EPHX2THRBCYP2C9 | |
| SCHEMBL4711516 | 0.73 | THRB (0.34) | ALDH1A1HSD11B1EPHX2THRBCYP2C9 | |
| SCHEMBL31084441 | 0.73 | MAPK1 (0.36) | SMN1; SMN2ALDH1A1HSD11B1EPHX2LMNA | |
| SCHEMBL2053505 | 0.73 | THRB (0.36) | KMT2ASMN1; SMN2ALDH1A1MEN1THRB | |
| SCHEMBL4582380 | 0.72 | EPHX2 (0.40) | ALDH1A1HSD11B1EPHX2THRBCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1308338-C | Phosphorus compound | DAICEL CHEM (JP) | 2007-04-04 | — | — | CN | disclosed |
| CN-1224625-C | Phosphorus-containing compound | DAICEL CHEM (JP) | 2005-10-26 | — | — | CN | disclosed |
| CN-1597686-A | Phosphorus compound | DAICEL CHEM (JP) | 2005-03-23 | — | — | CN | disclosed |
| US-6794528-B2 | HEAT RESISTANCE, FLAME RETARDERS, STABILIZERS; REACTING DIALCOHOL COMPOUND WITH A PHOSPHYL OXYCHLORIDE COMPOUND | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-09-21 | — | — | US | disclosed |
| US-20030109736-A1 | Phosphorus compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-06-12 | — | — | US | disclosed |
| EP-1277758-A1 | PHOSPHORUS COMPOUND | Daicel Chemical Industries, Ltd. (JP) | 2003-01-22 | — | — | EP | disclosed |
| CN-1383429-A | Phosphorus-containing compound | DAICEL CHEM (JP) | 2002-12-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109736-A1 | Phosphorus compound | NR4A1, POLL, NR0B1 | KMT2A 1756/4885SMN1; SMN2 3216/4885ALDH1A1 3180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.